Clinical Trial Update: A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BBI608 in combination with temozolomide in adults with recurrent or progressed glioblastoma (Phase 1/Phase 2) completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• BBI608
• Temozolomide (Temozolomide)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-09-24